Skip to main content
. Author manuscript; available in PMC: 2021 Jan 13.
Published in final edited form as: J Infect Dis. 2019 Apr 19;219(10):1605–1615. doi: 10.1093/infdis/jiy702

Table 2.

Characteristics of Index Case and Household Contacts Associated With Household Secondary Infection Risk (SIR) Analysis Including Individuals Testing Influenza Positive in the First 8 Days, Klerksdorp and Pietermaritzburg, South Africa, 2013–2014

Characteristic SIR,a n/N (%) Univariate, OR (95% CI) P Multivariable, OR (95% CI) P
Index case characteristics
Age group, y
 <1 0/6 (0) Not estimated Not estimated
 1–4 24/62 (39) 2.5 (1.2–5.6) .019 3.6 (1.2–11.3) .026
 5–14 17/86 (20) Reference Reference Reference Reference
 15–24 11/56 (20) 1.0 (0.4–2.7) .987 1.9 (0.6–6.4) .280
 25–44 21/85 (25) 1.3 (0.6–3.2) .520 8.0 (1.8–36.7) .007
 45–64 4/38 (11) 0.5 (0.1–3.0) .426 2.6(0.3–22.6) .395
 ≥65 0/0 (0) Not included Not included
Sex
 Male 30/122 (25) 1.1 (0.6–1.9) .706
 Female 47/211 (22) Reference Reference
Site
 Klerksdorp 49/177 (28) 1.8 (0.9–3.5) .111
 Edendale 28/156 (18) Reference Reference
Year
 2013 19/108 (18) Reference .149
 2014 58/225 (26) 1.6 (0.9–3.2)
HIV status
 Uninfected 59/220 (27) Reference Reference Reference Reference
 Infected 18/113 (16) 0.5 (0.2–1.3) .158 0.2 (0.1–0.6) .007
HIV status
 Uninfected 59/215 (27) Reference Reference
 Infected, receiving 13/77 (17) 0.5 (0.2–1.7) .304
ART 5/36 (14)
 Infected, not receiving ART 0.4 (0.2–0.9) .034
Non-HIV underlying illnessd
 Absent 77/326 (24) Not estimated
 Present 0/7 (0)
Currently taking treatment for tuberculosis
 No 61/281 (22) Reference .002
 Yes 9/15 (60) 5.4 (2.4–12.2)
Alcohol use
 No 24/89 (27) 2.8 (0.6–8.0) .171
 Yes 5/43 (12) Reference
Smoking
 No 25/108 (34) 1.5 (0.5–7.0) .591
 Yes 4/24 (17) Reference
Influenza type
 A 71/294 (24) Reference .579
 B 12/39 (31) 1.4 (0.4–4.7)
Influenza type and subtype
 H3N2 52/219 (24) 1.4 (0.7–2.9) .405
 H1N1pdm09 12/65 (18) Reference Reference
 A (Unsubtyped) 2/10 (20) 1.1 (0.2–7.9) .921
 B 11/39 (28) 1.7 (0.7–6.4) .404
Influenza Ct value
 <30 64/243 (26) 2.3 (1.1–4.8) .036 2.7 (1.2–6.1) .020
 ≥30 12/88 (14) Reference Reference Reference Reference
Pneumococcal colonization
 Yes 37/131 (28) 0.9 (0.4–2.4) .909
 No 22/75 (29) Reference
Viral coinfectionb
 Yes 15/64 (23) 1.0 (0.5–2.2) .947
 No 62/269 (23) Reference
Received influenza vaccine
 Yes 0/5 (0) Not estimated
 No 69/298 (23)
Sore throat
 Yes 21/135 (16) 0.4 (0.2–0.9) .032
 No 50/173 (29) Reference Reference
Myalgia
 Yes 9/64 (14) 0.5 (0.2–1.4) .176
 No 62/244 (25) Reference
Household contact characteristics
Age group, y
 <1 3/6 (50) 3.3 (0.6–13.6) .095 1.6 (0.3–5.8) .466
 1–4 13/28 (46) 2.8 (1.1–76) .035 3.5 (1.2–10.3) .021
 5–14 19/82 (23) Reference Reference Reference Reference
 15–24 11/76 (14) 0.6 (0.2–1.3) .169 0.5 (0.2–1.2) .115
 25–44 16/84 (19) 0.8 (0.4–1.7) .528 0.8 (0.3–1.7) .535
 45–64 9/40 (23) 1.0 (0.3–2.7) .941 0.9 (0.3–3.0) .832
 ≥65 6/17 (35) 1.8 (0.6–5.5) .294 2.4 (0.6–9.3) .216
Sex
 Male 26/109 (24) 1.0 (0.6–1.8) .865
 Female 46/200 (23) Reference
HIV status
 Uninfected 38/140 (27) Reference .454
 Infected 5/26 (19) 0.6 (0.2–2.1)
Non-HIV underlying illnessd
 Absent 75/321 (23) Reference .573
 Present 2/12 (17) 0.5 (0.1–2.9)
Alcohol usec
 No 30/145 (21) Reference Reference
 Yes 10/57 (18) 0.8 (0.3–1.8) .647
Smokingc
 No 33/169 (21) Reference Reference
 Yes 7/33 (21) 1.1 (0.4–2.8) .825
Received influenza vaccine
 Yes 2/12 (17) Reference .734
 No 54/259 (21) 1.3 (0.3–6.6)
Share a bed with the index case
 Yes 29/86 (34) 2.0 (1.1–3.8) 0.021 2.7 (1.3–5.5) 0.009
 No 45/226 (20) Reference Reference Reference
Number of people in household
 2–3 12/85 (14) Reference Reference Reference Reference
 4–6 43/195 (23) 1.7 (0.7–4.0) .213 2.3 (0.7–7.6) .180
 7+ 22/53 (42) 4.3 (1.4–13.3) .012 6.1 (1.3–28.4) .022
People per room
 <3 52/225 (23) Reference .358
 ≥3 30/108 (28) 1.3 (0.8–2.2)
Number of children aged <5 years in house
 ≤2 64/315 (20) Reference <.001
 >2 13/18 (72) 10.2 (7.1–14.7)

Missing data: Out of 87 index cases included in the analysis, data were missing for alcohol use (n = 4), smoking (n = 4), current tuberculosis treatment (n = 8), received influenza vaccine (n = 8), influenza cycle threshold value (n = 1), pneumococcal colonization (n = 34), symptoms (sore throat, runny nose, headache and myalgia) (n = 7). Out of 333 household contacts included in the analysis, data were missing for contact sex (n = 24), contact HIV status (n = 167), contact alcohol use (n = 15), contact smoking (n = 15), contact influenza vaccine receipt (n = 62), contact sharing a bed with index (n = 21). There were 70 (21%) household contacts missing 1 follow-up sample, 20 (6%) missing 2 samples, and 31 (9%) missing 3 samples.

OR and P values for all variables included in the multivariable models are displayed in the 2 right hand columns of the table. No pairwise interactions were included in the multivariable models as no interaction terms were found significant. Additional factors evaluated but not found to be associated with SIR were sharing eating utensils with the index case and avoiding contact with the sick household member.

Abbreviations: ART, antiretroviral therapy; CI, confidence interval; Ct, cycle threshold; HIV, human immunodeficiency virus; OR, odds ratio.

a

Secondary infection risk (SIR) = Number of secondary cases in the household/number of exposed household contacts.

b

Test positive on polymerase chain reaction for at least 1 of parainfluenza virus types 1–3, respiratory syncytial virus, enterovirus, human metapneumovirus, adenovirus or human rhinovirus.

c

Among individuals aged >15 years.

d

Asthma, other chronic lung disease, chronic heart disease, liver disease, renal disease, diabetes mellitus, immunocompromising conditions excluding HIV infection, neurological disease, or pregnancy. Comorbidities were considered absent in cases for which the medical records stated that the patient had no underlying medical condition or when there was no direct reference to that condition.